A meta-analysis of phase III trials evaluating the predictive value of HER2 and topoisomerase II alpha in early breastcancer patients treated with CMF or anthracycline-based adjuvant therapy Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Di Leo, A
  • Isola, J
  • Piette, F
  • Ejlertsen, B
  • Pritchard, Kathleen
  • Bartlett, JMS
  • Desmedt, C
  • Larsimont, D
  • Tanner, M
  • Mouridsen, H
  • O'Malley, FP
  • Twelves, C
  • Cardoso, F
  • Poole, CJ
  • Piccart, MJ
  • Buyse, ME

publication date

  • January 15, 2009